Chronic ventricular arrhythmias: Comparative drug effectiveness and toxicity

M. A. Warnowicz; P. Denes

doi:10.1016/0033-0620(80)90022-5

Chronic ventricular arrhythmias: Comparative drug effectiveness and toxicity

M. A. Warnowicz, P. Denes^*

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

The management of chronic arrhythmias begins with the identification of the patients to receive antiarrhythmic therapy. Two broad subgroups of patients can be identified (Fig. 1).

Original language	English (US)
Pages (from-to)	225-236
Number of pages	12
Journal	Progress in Cardiovascular Diseases
Volume	23
Issue number	3
DOIs	https://doi.org/10.1016/0033-0620(80)90022-5
State	Published - 1980

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/0033-0620(80)90022-5

Fingerprint Dive into the research topics of 'Chronic ventricular arrhythmias: Comparative drug effectiveness and toxicity'. Together they form a unique fingerprint.

Cite this

@article{552aea1f1974409f810b18cd9cd553bb,

title = "Chronic ventricular arrhythmias: Comparative drug effectiveness and toxicity",

abstract = "The management of chronic arrhythmias begins with the identification of the patients to receive antiarrhythmic therapy. Two broad subgroups of patients can be identified (Fig. 1).",

author = "Warnowicz, {M. A.} and P. Denes",

year = "1980",

doi = "10.1016/0033-0620(80)90022-5",

language = "English (US)",

volume = "23",

pages = "225--236",

journal = "Progress in Cardiovascular Diseases",

issn = "0033-0620",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Chronic ventricular arrhythmias

T2 - Comparative drug effectiveness and toxicity

AU - Warnowicz, M. A.

AU - Denes, P.

PY - 1980

Y1 - 1980

N2 - The management of chronic arrhythmias begins with the identification of the patients to receive antiarrhythmic therapy. Two broad subgroups of patients can be identified (Fig. 1).

AB - The management of chronic arrhythmias begins with the identification of the patients to receive antiarrhythmic therapy. Two broad subgroups of patients can be identified (Fig. 1).

UR - http://www.scopus.com/inward/record.url?scp=0019088596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019088596&partnerID=8YFLogxK

U2 - 10.1016/0033-0620(80)90022-5

DO - 10.1016/0033-0620(80)90022-5

M3 - Article

C2 - 6107955

AN - SCOPUS:0019088596

VL - 23

SP - 225

EP - 236

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

SN - 0033-0620

IS - 3

ER -